Immune-repertoire aging clock in Chinese adults and post-COVID-19 cases
In leukocyte DNA from 195 healthy Chinese adults aged 25–93 and 94 post-COVID-19 cases, aging correlated with shorter CDR3 sequences and lower receptor diversity; these changes were intensified after COVID-19, and a LightGBM-based immune-repertoire clock indicated accelerated biological aging in post-COVID-19 individuals. [1]
Automatic summary · not editorially reviewed
The key findings
In 195 healthy Chinese adults aged 25–93, aging correlated with shorter CDR3 sequences and reduced receptor diversity. [1]
Post-COVID-19 cases showed intensified repertoire changes, including expanded SARS-CoV-2- and Mycobacterium tuberculosis-related clones. [1]
A LightGBM-based immune-repertoire clock indicated accelerated biological aging and reduced intrinsic capacity in post-COVID-19 individuals. [1]
The source at a glance
- Study type / format
- Abstract of a cross-sectional comparison using high-throughput CDR3 sequencing and a LightGBM-based aging clock.
- Population / context
- 195 healthy Chinese individuals aged 25–93 years and 94 post-COVID-19 cases.
- Summary based on
- Study abstract
- Original publication
- July 1, 2026
Immune repertoire in 195 healthy Chinese adults
The study analyzed leukocyte DNA from 195 healthy Chinese individuals aged 25–93 years using high-throughput sequencing of CDR3, the variable region of T- and B-cell receptors. Aging correlated with shorter CDR3 sequences, reduced diversity of VDJ genes and V-J combinations, and declining T- and B-cell clonotype counts (179.7 and 507 per 3 years). Expanded hyperexpanded T-cell clones and large B-cell clones were also seen, with a critical turning point around 60 years. These are associations in one non-European population, not proof of cause.
Supporting source [1]
Post-COVID-19 cases showed intensified repertoire changes
Comparing 94 post-COVID-19 cases with the healthy group, the authors report intensified changes: altered amino acid usage, diminished diversity, and expanded clones related to SARS-CoV-2 and Mycobacterium tuberculosis. They built a LightGBM-based immune-repertoire aging clock and report accelerated biological aging (increased cAgeDiff) and reduced intrinsic capacity in post-COVID-19 individuals. The abstract does not report how long after infection samples were taken, so timing of exposure relative to measurement is unclear.
Supporting source [1]
Abstract-only scope of the immune clock study
This explainer is based on the abstract only; the full text was not reviewed. The design is a comparison of healthy and post-COVID-19 groups using sequenced leukocyte DNA, not a longitudinal study showing that COVID-19 causes aging. The clock is a proposed research tool, not a validated clinical test. The authors describe potential clinical applications for age-related immune decline and post-COVID-19 syndromes, but the abstract reports no intervention or outcome benefit.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. The abstract does not report sample timing after infection, follow-up, or whether the clock was validated in independent cohorts. Associations do not establish that COVID-19 causes aging, and the clock is a proposed research tool, not a clinical test.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Gao X, Li SJ, Li J, Wang ZH, Zeng LT, Ma YQ, Dang YM, Zhang YM, Liu HL, Zhang LQ, Pang J, Cui J, Zhang TM, Cai JP. · europepmc.org · July 1, 2026